Lenalidomide is a cancer drug. It is also known by its brand name Revlimid. It is a treatment for:

female who can become pregnant while taking REVLIMID, during any breaks. (interruptions) in your treatment with REVLIMID, and for 4 weeks after stopping ...

Lenalidomide (Revlimid) is a targeted therapy drug used to treat myeloma, some types of lymphoma and myelodysplastic syndromes (MDS).

You'll usually keep taking Revlimid for as long as you tolerate the medication. If your multiple myeloma worsens, your doctor may recommend stopping treatment.

Revlimid is a medicine used for the treatment of certain cancers and serious conditions affecting blood cells and bone marrow.

Aug 24, 2023 · REVLIMID in combination with dexamethasone is indicated for the treatment of adult patients with multiple myeloma (MM).

REVLIMID is indicated as maintenance therapy in adult patients with MM following autologous hematopoietic stem cell transplantation (auto-HSCT). REVLIMID is not ...

Revlimid® (lenalidomida) é indicado para o tratamento de pacientes com síndrome mielodisplásica onde parte do cromossomo 5 é ausente (deleção 5q), com ou sem ...

Apr 15, 2019 · If you become pregnant during your treatment or within 30 days after your treatment, your doctor will contact the REVLIMID REMS program, the ...

Jan 27, 2022 · Lenalidomide treatment in combination with dexamethasone must not be started if the Absolute. Neutrophil Count (ANC) < 1.5 x 109/L, and platelet ...